These data not only indicate that methylation-induced suppression of YAP and TAZ render IDHmut glioma cells more vulnerable to HDACi, but that YAP/TAZ might serve as a predictive biomarker for HDACi response across all cancers. This evidence concerns the gene YAP1 and glioma.